Oversight Director
Thermo Fisher Scientific - Shanghai, Shanghai, China
Posted May 8, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified last checked Jun 13, 2026
- Salary
- Not verified
- 401(k) match
- Listed Source: EMPLR_CONTRIB_INCOME_AMT. source Last checked Jun 13, 2026.
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $81,444 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +6.9% - Faster than average
Matched to SOC 29-1141 - Healthcare aggregate by role bucket.
Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Oversight Director Shanghai, Shanghai, China Embrace the opportunity to become an Oversight Director and drive impactful clinical research projects at Thermo Fisher Scientific. Lead cross-functional teams, manage strategic proposals, and ensure regulatory compliance while supporting global biotech initiatives. Shape the future of clinical trials and make a difference in global health outcomes. Grow your career with a world leader in life sciences.
Read the full description at thermofisher.wd5.myworkdayjobs.com. FewerJobs shows a source-linked preview and links to the original posting.
Apply link not verified; last-live date unavailable.
What verified means
Verified means a displayed claim has a recorded source field, a source URL when available, and a timestamp showing when FewerJobs checked or enriched the evidence.